Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7572784 Compounds and methods for inhibiting mitotic progression

Patent 7572784 was granted and assigned to Millennium Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

1

Patent attributes

Current Assignee

Millennium Pharmaceuticals

1

Patent Jurisdiction

United States Patent and Trademark Office

1

Patent Number

Patent Inventor Names

Christopher F. Claiborne1

Gabriel S. Weatherhead1

Lloyd J. Payne1

Richard J. Boyce1

Stephen G. Stroud1

Stuart Travers1

Todd B. Sells1

Tricia J. Vos1

Date of Patent

August 11, 2009

1

Patent Application Number

111278551

Date Filed

May 12, 2005

1

Patent Citations Received

Loading...

2

US Patent 11786470 Solid pharmaceutical compositions and processes for their production

US Patent 11958855 Aurora kinase inhibitors for inhibiting mitotic progression

3

Patent Primary Examiner

Brenda L Coleman

1

Patent abstract

This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7572784 Compounds and methods for inhibiting mitotic progression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.